Lv21
125 积分 2026-06-10 加入
In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events
17天前
已完结
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
17天前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
